Find Docarpamine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 74639-40-0, Tanadopa, Docarpamine [inn], Docarpamina, Ta-870, Rpq57d8s72
Molecular Formula
C21H30N2O8S
Molecular Weight
470.5  g/mol
InChI Key
ZLVMAMIPILWYHQ-INIZCTEOSA-N
FDA UNII
RPQ57D8S72

Docarpamine
1 2D Structure

Docarpamine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[4-[2-[[(2S)-2-acetamido-4-methylsulfanylbutanoyl]amino]ethyl]-2-ethoxycarbonyloxyphenyl] ethyl carbonate
2.1.2 InChI
InChI=1S/C21H30N2O8S/c1-5-28-20(26)30-17-8-7-15(13-18(17)31-21(27)29-6-2)9-11-22-19(25)16(10-12-32-4)23-14(3)24/h7-8,13,16H,5-6,9-12H2,1-4H3,(H,22,25)(H,23,24)/t16-/m0/s1
2.1.3 InChI Key
ZLVMAMIPILWYHQ-INIZCTEOSA-N
2.2 Other Identifiers
2.2.1 UNII
RPQ57D8S72
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Do Carpamine

2. N-(n-acetyl-l-methionyl)-o,o-bis(ethoxycarbonyl)dopamine

3. Ta 870

4. Ta-8704

2.3.2 Depositor-Supplied Synonyms

1. 74639-40-0

2. Tanadopa

3. Docarpamine [inn]

4. Docarpamina

5. Ta-870

6. Rpq57d8s72

7. Dtxsid1057820

8. [4-[2-[[(2s)-2-acetamido-4-methylsulfanylbutanoyl]amino]ethyl]-2-ethoxycarbonyloxyphenyl] Ethyl Carbonate

9. (-)-(s)-2-acetamido-n-(3,4-dihydroxyphenethyl)-4-(methylthio)butyramide Bis(ethyl Carbonate) (ester)

10. Docarpaminum

11. Do Carpamine

12. Docarpaminum [inn-latin]

13. Docarpamina [inn-spanish]

14. (s)-4-(2-(2-acetamido-4-(methylthio)butanamido)ethyl)-1,2-phenylene Diethyl Dicarbonate

15. Tanadopa (tn)

16. Unii-rpq57d8s72

17. Ta-8704

18. N-(n-acetyl-l-methionyl)-o,o-bis(ethoxycarbonyl)dopamine

19. Docarpamine (jan/inn)

20. Docarpamine [mi]

21. Docarpamine [jan]

22. Docarpamine [mart.]

23. Docarpamine [who-dd]

24. Schembl219671

25. Chembl2106351

26. Dtxcid8031609

27. Schembl23356827

28. Chebi:31513

29. Tox21_113707

30. Ncgc00249931-01

31. Carbonic Acid, 4-(2-((2-(acetylamino)-4-(methylthio)-1-oxobutyl)amino)ethyl)-1,2-phenylene Diethyl Ester, (s)-

32. Cas-74639-40-0

33. Ns00127253

34. D01903

35. Q27288234

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 470.5 g/mol
Molecular Formula C21H30N2O8S
XLogP32.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count16
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area155
Heavy Atom Count32
Formal Charge0
Complexity619
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Dopamine Agonists

Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty